PREVIOUS
✖
ChAdOx1 COVID-19 vaccine
July 23 , 2020
1462 days
755
0
- It was jointly developed by British-Swedish company AstraZeneca and the University of Oxford.
- It has been found to be safe and induced an immune response in early-stage clinical trial.
- Serum institute of India, the partner in the development of Oxford Vaccine, is planning to start the clinical trials in India.
- The company is the world's largest vaccine producer by number of doses produced.
Leave a Reply
Your Comment is awaiting moderation.